South Africa Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The South Africa Cardiovascular Devices Market is segmented by device type (diagnostic and monitoring devices (Electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices), and therapeutic and surgical devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Heart Valves, Stents, Other Therapeutic and Surgical Devices). The report offers the value in ( USD million) for all the above segments.

South Africa Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Africa Cardiovascular Devices Market Size

View Global Report
South Africa Cardiovascular Device Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 6.00 %
Market Concentration Low

Major Players

South Africa Cardiovascular Device Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of South Africa Cardiovascular Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

South Africa Cardiovascular Devices Market Analysis

The South Africa Cardiovascular Devices Market is expected to register a CAGR of 6% during the forecast period.

The COVID-19 pandemic affected the manufacturing of cardiovascular devices. The decrease in cardiovascular disease diagnoses due to healthcare resources allocated to COVID-19 patients had a detrimental influence on the market. According to the study published in Global Heart in March 2021, about 19% of hospitalized cases had evidence of cardiac injury. SARS-COV was associated with cardiomyopathy. Other cardiovascular findings include hypotension, arrhythmias, and sudden death. Persistent tachycardia was the most typical arrhythmia found in 72% of cases that persisted for weeks in COVID-19 patients. Thus, the cardiac disease market was significantly impacted during the pandemic as the number of cardiac incidences increased with COVID-19. However, the market has recovered well since the limitations were relaxed. The market recovery over the previous two years has been led by the increasing prevalence of heart illnesses and new product introductions.

The market is driven by the rising burden of cardiovascular diseases, technological advancement in cardiovascular devices, and increased awareness about cardiac diseases and treatment. The increasing burden of various coronary heart disorders, including cardiomyopathy and stroke, which account for most deaths from cardiac causes, is also driving the market. Cardiovascular diseases, the leading causes of death in South Africa, are the most prevalent ailments identified among the population. According to a study published in the Cardiovascular Journal of Africa in May 2021, every hour, five people have suffered from a stroke, and ten people suffered a heart attack. Additionally, obesity is a risk factor for CVD, and the growing prevalence of obesity will propel market growth. According to the study published in BMJ Open Journal in February 2022, adults without private health insurance in South Africa have hypertension in about 8.22 million cases annually. According to estimates, hypertension contributes to 6,100 new cases of chronic renal and, 14,000 cases of ischemic heart disease annually, and 13,300 strokes. Thus, the growing prevalence of cardiovascular diseases will propel market growth.

Furthermore, various initiatives launched by the government and private organizations in the country are expected to boost the market. In March 2022, WHF (World Hewart Federation) organized a site visit to Maputo, Mozambique, as part of the Colours to Save Hearts program. The WHF initiative Colors to Save Hearts, which is run by the Mozambique Institute for Health Education and Research and implemented by the National Health Institute of Mozambique (INS), aims to educate parents, teachers, and kids about the connection between rheumatic heart disease (RHD) and sore throats. They also shared how to recognize the symptoms of RHD and what to do when they first appear.

Thus, all factors mentioned above, such rising prevalence of cardiac diseases and government initiatives, are expected to boost the market in the country over the forecast period. However, a stringent regulatory scenario is expected to restrain the market growth over the forecast period.

South Africa Cardiovascular Devices Industry Overview

The South African cardiovascular device market is moderately competitive and consists of several major players. The major players in the South African cardiovascular devices market are Abbott Laboratories, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., Edwards Lifesciences, GE Healthcare, Medtronic PLC, Siemens AG, and W. L. Gore & Associates.

South Africa Cardiovascular Devices Market Leaders

  1. Abbott Laboratories

  2. Boston Scientific Corporation

  3. Cardinal Health, Inc.

  4. Edwards Lifesciences

  5. Medtronic PLC

  6. *Disclaimer: Major Players sorted in no particular order
South Africa Cardiovascular Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

South Africa Cardiovascular Devices Market News

  • June 2022- South African Society of Cardiovascular Intervention represents South Africa in a virtual hub Endovascular Cardiac Complications session.
  • September 2021- Merck Foundation provides 100 new Cardiovascular preventive experts to mark World Heart Day 2021 in 25 countries in Africa and Asia.

South Africa Cardiovascular Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Cardiovascular Disorders
    • 4.2.2 Growing Public Awareness and Rapid Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Procedures and Stringent Regulatory Scenario
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Device Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Electrocardiogram (ECG)
    • 5.1.1.2 Remote Cardiac Monitoring
    • 5.1.1.3 Other Diagnostic and Monitoring Devices
    • 5.1.2 Therapeutic and Surgical Devices
    • 5.1.2.1 Cardiac Assist Devices
    • 5.1.2.2 Cardiac Rhythm Management Device
    • 5.1.2.3 Catheter
    • 5.1.2.4 Grafts
    • 5.1.2.5 Heart Valves
    • 5.1.2.6 Stents
    • 5.1.2.7 Other Therapeutic and Surgical Devices

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Canon Medical Systems Corporation
    • 6.1.4 Cardinal Health, Inc.
    • 6.1.5 Edwards Lifesciences
    • 6.1.6 GE Healthcare
    • 6.1.7 Medtronic PLC
    • 6.1.8 Siemens AG
    • 6.1.9 W. L. Gore & Associates
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

South Africa Cardiovascular Devices Industry Segmentation

As per the scope of the report, cardiovascular devices are for diagnosing heart diseases and treating related health problems. The South Africa Cardiovascular Devices Market is segmented by device type (diagnostic and monitoring devices (Electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices), and therapeutic and surgical devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Heart Valves, Stents, Other Therapeutic and Surgical Devices). The report offers the value in ( USD million) for all the above segments.

By Device Type Diagnostic and Monitoring Devices Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices
Need A Different Region or Segment?
Customize Now

South Africa Cardiovascular Devices Market Research FAQs

What is the current South Africa Cardiovascular Devices Market size?

The South Africa Cardiovascular Devices Market is projected to register a CAGR of 6% during the forecast period (2025-2030)

Who are the key players in South Africa Cardiovascular Devices Market?

Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Edwards Lifesciences and Medtronic PLC are the major companies operating in the South Africa Cardiovascular Devices Market.

What years does this South Africa Cardiovascular Devices Market cover?

The report covers the South Africa Cardiovascular Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the South Africa Cardiovascular Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

South Africa Cardiovascular Devices Industry Report

Statistics for the 2025 South Africa Cardiovascular Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South Africa Cardiovascular Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

South Africa Cardiovascular Devices Report Snapshots